RMD Technical Analysis

As of date:	4/24/2024
RMD stock price:	183.78
RMD 50 DMA:	185.92
RMD 200 DMA:	171.90
RMD MACD (200-50):	-14.02
RMD RSI:	48.57

Extremely Overbought
	48.57
Extremely Oversold

Also see:
RMD Market Cap History
RMD Shares Outstanding History
RMD YTD Return

Quotes delayed 20 minutes

Free RMD Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

Farmers & Merchants Bancorp (FMAO) Shares Cross Below 200 DMA
1 hour, 15 minutes ago

Plexus (PLXS) Shares Cross Above 200 DMA
1 hour, 20 minutes ago

HBI Crosses Below Key Moving Average Level
1 hour, 29 minutes ago

VTES Crosses Critical Technical Indicator
1 hour, 30 minutes ago

MVT Crosses Below Key Moving Average Level
1 hour, 37 minutes ago

Putnam Managed Municipal Income Trust (PMM) Shares Cross Below 200 DMA
1 hour, 40 minutes ago

iShares CMBS Breaks Below 200-Day Moving Average - Notable for CMBS
1 hour, 40 minutes ago

MCAN Mortgage Crosses Above Key Moving Average Level
1 hour, 47 minutes ago

Mineralys Therapeutics Breaks Below 200-Day Moving Average - Notable for MLYS
4 hours, 14 minutes ago

Day One Biopharmaceuticals (DAWN) Shares Cross Below 200 DMA
4 hours, 14 minutes ago

Arvinas (ARVN) Shares Cross Below 200 DMA
5 hours, 3 minutes ago

OPRA Crosses Below Key Moving Average Level
5 hours, 4 minutes ago

DCPH Makes Notable Cross Below Critical Moving Average
5 hours, 4 minutes ago

FENC Makes Notable Cross Below Critical Moving Average
5 hours, 4 minutes ago

SVRA Makes Notable Cross Below Critical Moving Average
5 hours, 4 minutes ago

More Technical Analysis News

ResMed is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Co.'s operating segments are: Sleep and Respiratory Care, which relates primarily to the sale of its products that are therapy-based equipment; and Software as a Service, which relates to the provision of software access with ongoing support and maintenance services as well as services such as training and consulting.

When researching a stock like ResMed, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from RMD Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for RMD stock — the real life supply and demand for the stock over time — and examines that data in different ways.

10 Most Oversold S&P 500 Stocks

10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying

10 ETFs With Most Upside To Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active S&P Call & Put Options

Video: Technical Analysis

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

ResMed (RMD) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

RVTY Technical Analysis
STE Technical Analysis
SYK Technical Analysis
TECH Technical Analysis
TFX Technical Analysis
TMO Technical Analysis
UHS Technical Analysis
VRTX Technical Analysis
VTRS Technical Analysis
WAT Technical Analysis
More Healthcare companies »

Join TechnicalAnalysisChannel.com
Create a FREE account to continue
Already have an account? LOG IN

Full Disclaimer & Terms of Use and Privacy Policy. Important: If you are in Canada or the European Union, you must click here for alternate registration page.

✓

Immediate access to our RMD Technical Analysis page as well as our full coverage universe of stocks

✓

Complimentary report on monthly dividend paying stocks

✓

Daily market updates from our Contrarian Outlook team

✓

Join FREE with just your email address

Welcome back!

TechnicalAnalysisChannel.com and parent company BNK Invest, Inc. value our relationship with you and would like to continue providing accurate and tailored communications to fit your investing needs. To receive our publications and other relevant communications, Canada's anti-spam legislation (''CASL'') and the European Union's General Data Protection Regulation (''GPDR'') requires us to obtain your express consent. Please provide your consent to continue. In any email we send, you will be given the option to withdraw your consent or unsubscribe from any or all of our newsletters or publications at any time.

RMD Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2024, All Rights Reserved